Sterling Biotech has informed that the meeting of the Board of Directors of the Company is scheduled to be held on February 14, 2017, to review, consider and adopt the Unaudited Financial Results for the period ended on December 31, 2016, along with the Limited Review Report of the Statutory Auditor thereon.
The above information is a part of company’s filings submitted to BSE.